Physician

Rajiv Mallik, M.D.

According to 2025 Medicare claims, Rajiv Mallik, M.D. (NPI: 1285806935) practices cardiac electrophysiology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE PLLC (NPI: 1982632907; TIN: 421085919) and primary practice location at 61265-7127. Mallik is affiliated with the IRCCO (ACO ID: A2619), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mallik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,842 traditional Medicare patients, billed 9,847 HCPCS/CPT codes, and received $488,901 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,156 prescription claims across 1,374 beneficiaries totaling $2,147,476 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 17 claims. Open Payments data shows 17 records totaling $496. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $125,149 to $488,901. Similarly, Part D prescription costs have moved sharply higher in recent years, from $131,425 to $2,147,476. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	837	2,864	$125,149
2016	1,208	3,140	$125,561
2017	1,304	7,174	$289,969
2018	1,664	9,096	$403,026
2019	2,185	12,233	$392,681
2020	1,839	11,279	$353,889
2021	2,188	12,268	$403,029
2022	1,775	11,896	$396,117
2023	1,879	9,237	$449,507
2024	1,842	9,847	$488,901

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	267	1,720	$131,425
2016	341	2,261	$210,646
2017	341	1,815	$146,577
2018	477	3,043	$383,468
2019	625	4,142	$680,680
2020	739	4,900	$931,878
2021	863	5,502	$1,199,351
2022	970	6,195	$1,488,009
2023	1,144	6,806	$1,767,832
2024	1,374	8,156	$2,147,476

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	22	$41,470
2017	N/R	N/R	N/R
2018	N/R	17	$35,554
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	601	857	$86
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	249	688	$21
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	332	924	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	764	1,187	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	661	870	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,427	80,592	$1,544,193
Xarelto	Rivaroxaban	170	10,970	$199,962
Entresto	Sacubitril/Valsartan	158	8,589	$186,276
Multaq	Dronedarone Hcl	29	1,609	$33,893
Jardiance	Empagliflozin	30	1,710	$33,456

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$496	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajiv Mallik, M.D.?

Tedicare shows public-source Medicare data for Rajiv Mallik, M.D. (NPI 1285806935), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajiv Mallik, M.D. have ACO affiliation data?

Rajiv Mallik, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rajiv Mallik, M.D.?

Rajiv Mallik, M.D. is linked to CARDIOVASCULAR MEDICINE PLLC (billing NPI 1982632907) in the available physician profile data.

Does Rajiv Mallik, M.D. have Open Payments data?

Rajiv Mallik, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.